OWLT
T3Owlet, Inc.
Loading chart…
OverviewOwlet, Inc. provides a digital platform with FDA-cleared smart devices like Dream Sock and Cam, monitoring babies' health and sleep. The company is evolving int
Owlet, Inc. provides a digital platform with FDA-cleared smart devices like Dream Sock and Cam, monitoring babies' health and sleep. The company is evolving into a data and services platform, shifting to a subscription-first model, Owlet360, offering AI-driven health insights and telehealth. Subscription revenue is now approximately 9% of total. They sell primarily to parents via retail and online, expanding hospital partnerships.
Search Keywords Brand Product
- Dream Sock
- Owlet360
- BabySat
- Owlet OnCall
- Dream Duo
- Dream Sight
- smart baby monitor
- baby oxygen monitor
- pediatric telehealth platform
- AI baby monitor
- subscription baby monitor
- infant health monitoring
- early childhood health tech
- parenting journey platform
- FDA cleared baby monitor
- digital health for infants
Search Keywords Event Phrases
- Owlet Q2 2026 earnings
- Amazon FDA clearance deadline
- Owlet Web Pay rollout
Search Keywords Policy Regulatory
- Kids Internet and Digital Safety Act
- KIDS Act
- FDA clearance baby monitors
- Amazon baby monitor policy
- What They Do (Plain English & Analogies)
- Owlet, Inc. acts like a smart guardian for babies, providing parents with devices and services that offer peace of mind by monitoring their child's health and sleep at home. Imagine a tiny, comfortable sock that your baby wears, which quietly keeps an eye on their oxygen levels and heart rate, much like a miniature, non-invasive hospital monitor. They also offer smart cameras so parents can see and hear their baby from anywhere. Beyond just hardware, Owlet is increasingly moving towards a 'subscription-first' model, offering services like Owlet360, which is like a personalized health coach for your baby, providing deeper insights and sleep guidance. They are also expanding 'Owlet OnCall,' which is like having a pediatrician on speed dial within their app, allowing parents to chat directly with a doctor using their baby's health data. Essentially, they're trying to make advanced infant monitoring and professional pediatric support easily accessible in every home, bridging the gap between hospital care and daily parenting. The company is evolving into a data and services platform for the earliest years of a child's life, aiming to bring together sleep, health monitoring, camera, and telehealth into a single Owlet experience.
- Very Brief History
- Founded in 2012 by a team of parents in Lehi, Utah, Owlet, Inc. began with the mission to empower parents with valuable data and insights about their children. The company has evolved from primarily selling hardware, like the Smart Sock, to focusing on a subscription-first, data-driven pediatric health platform, integrating AI and telehealth services. Co-founder Kurt Workman recently stepped back into the CEO role in April 2026 to lead this next phase of growth.
- "Street Stereotype"
- The company's "street stereotype" is that of a growth-oriented disruptor in pediatric health technology, focused on leveraging smart monitoring, data, and AI to provide peace of mind to parents. Investors are encouraged to evaluate its bullish upside and execution seriously, viewing it as a long-term investment in the evolving landscape of at-home infant care.
- Subsidiaries On Linked In*
- Owlet Baby Care, Inc. — Wholly-owned subsidiary mentioned in recent credit facility agreements.
- Customer Sectors & Example Clients
- Owlet's primary customer sector is direct-to-consumer parents and families. They also target the healthcare sector through hospital partnerships for their BabySat product. While specific client names are not provided in the transcript, their products are sold through major baby retailers such as Amazon, Babylist, Target, Walmart, Babies R Us, and BuyBuy Baby.
- New Customers / Segments They'Re Targeting
- Owlet is targeting new customers by firmly positioning itself as a data and services platform through subscription, aiming to win roughly 1 million new customers per year and retain those families for at least 2 years. They are expanding where parents can enroll in subscriptions, moving beyond in-app sign-up to the point of sale, and testing offers and bundles to make subscription at purchase a clear choice. They are also expanding access to their Owlet OnCall telehealth service more broadly, aiming to connect parents with clinical resources. The company is also focusing on extending the lifetime value of customers by making Owlet more valuable beyond the newborn window, into years 1 and 2 when sleep, health, and wellness take focus.
- Supply Chain And Sourcing Geographies
- Owlet's supply chain involves sourcing products and components from various geographies. The company has experienced "tariff cost impacts" and specifically mentioned "Thailand and Vietnam" in relation to tariff rates in previous periods, indicating that these countries are part of their sourcing or manufacturing footprint. In Q2 2026, Owlet received approximately $4 million in tariff refunds following a U.S. Supreme Court decision, which provided a one-time benefit to COGS and adjusted EBITDA.
- Sales Geographies And Expansion Plans
- Owlet currently sells its products in core global markets including the U.S., the U.K., Germany, France, Australia, and the Nordics. The company has noted strong international momentum, with Europe, particularly Germany, France, and Eastern Europe (like the Czech Republic), showing significant growth. They recently launched Owlet 360 subscription in a number of new non-English-speaking international markets, reaching an additional 5% to 10% of their user base. As part of a sharpened strategic focus, Owlet has deferred its planned entries into India, Hong Kong, and Singapore for the current year, redirecting investments to existing core markets with higher near-term return potential.
- How Key Themes May Help/Hurt
- The 'Child Care '24: Child Monitoring' theme strongly benefits Owlet. The persistent demand for childcare and rapid adoption of advanced monitoring technology, including AI-driven and subscription solutions, are key drivers that align directly with Owlet's strategic pivot. Owlet's FDA-cleared Dream Sock, its growing Owlet360 subscription model, and the expansion of its Owlet OnCall telehealth platform directly contribute to the bullish aspects of this theme by providing innovative, tech-driven solutions for proactive pediatric health and personalized guidance. The increasing government funding and expanded employer benefits for childcare, while not directly impacting Owlet's sales channels, indicate a broader societal prioritization of child well-being, which can indirectly support the market for advanced monitoring solutions. However, broader market headwinds for the baby monitoring category (excluding Owlet, it was down 19% in Q1) and potential new regulations like the Kids Internet and Digital Safety (KIDS) Act could introduce risks for tech adoption and monetization.
3 Main Long-Term Bull Details
- Owlet's strategic pivot to a multi-year subscription model (Owlet360) is gaining significant traction, with 130,000 paying subscribers and $1.1 million in Monthly Recurring Revenue (MRR) in Q2 2026. The goal is to build a recurring base of over 1 million subscribers by expanding the customer base, increasing subscription adoption, and extending subscriber relationships for at least 2 years.
- Owlet possesses a significant competitive moat as the first and only FDA-cleared baby monitor on the market (Dream Sock). This is a crucial differentiator, especially with Amazon's new policy requiring FDA clearance for vital sign monitoring products, which is expected to provide a long-term competitive benefit.
- The company is building a generational opportunity on AI, anchored by what it believes is the largest pediatric health data set in the world. This foundation enables increasingly personalized experiences across sleep, health, and wellness, using AI to turn data into meaningful insights and guidance throughout the parenting journey, creating a highly sticky product.
3 Main Long-Term Bear Details
- While Owlet reaffirmed its full-year 2026 revenue guidance of $118 million to $122 million, it noted a deliberately measured view for the second half due to aggressive competitor discounting prior to the Amazon FDA deadline and broader macro signals, including a cautious consumer spending environment. This indicates potential near-term top-line headwinds and market volatility.
- Although the Owlet OnCall telehealth platform is expanding access, it remains in a "test and learn" year, with meaningful new revenue streams expected only in the next year. This delays immediate financial impact from a key strategic initiative.
- The overall baby monitoring category, excluding Owlet, has experienced declines, suggesting broader market headwinds beyond Owlet's performance. This could indicate a challenging environment for sustained growth if overall category demand remains subdued.
- Competitors And Differentiation
- Owlet's primary competitors are other baby monitor companies. A key differentiator for Owlet is that its Dream Sock is the first and only FDA-cleared baby monitor on the market. This provides a significant competitive advantage, especially after Amazon's policy change effective August 10, 2026, which requires FDA clearance for baby monitoring products that measure and monitor vital signs to be sold on its platform. Owlet believes this could provide a longer-term competitive benefit as other companies would need to undergo the same rigor for FDA clearance. Despite aggressive discounting by several competitors, particularly around Prime Day, Owlet remained the #1 brand in baby monitoring and baby safety.
- Recent Performance & What The Market'S Focused On
- Owlet delivered a record Q2 2026, with total revenue reaching $33.9 million, a 29.9% increase year-over-year. Subscription revenue also hit a record of $3.2 million, up $2.4 million year-over-year, with 130,000 paying subscribers. The company reported a Q2 gross margin of 54% (excluding a $3.5 million tariff refund) and a record adjusted EBITDA of $2.9 million (excluding a $3.75 million tariff refund). Owlet reaffirmed its full-year 2026 revenue outlook of $118 million to $122 million but raised its full-year gross margin and adjusted EBITDA outlook, reflecting the one-time tariff refund. The market is focused on the continued growth of the Owlet360 subscription base, the expansion and monetization of the Owlet OnCall telehealth platform, the impact of Amazon's new FDA clearance requirement on competition, and the company's ability to maintain strong sell-through despite competitor discounting and broader macro signals.
- Revenue Segments And Estimated Mix
- Subscription Revenue — Mix: ~9.4%; Source: Q2 2026 transcript ($3.2M out of $33.9M total revenue); Trend: Grew $2.4M year-over-year, 130,000 paying subscribers, MRR > $1.1M, 36% penetration for Dream Sock in U.S.
- Product Brands
- Smart Sock
- Dream Sock
- Cam
- Dream Lab
- Dream Duo
- Owlet360
- Owlet OnCall
- BabySat
- Dream Sight
Bull / Bear DetailsOwlet, Inc. is accelerating its pivot to an AI-driven, subscription-first pediatric health platform, evidenced by record Q2 results, robust subscription growth,
Thesis
Owlet, Inc. is accelerating its pivot to an AI-driven, subscription-first pediatric health platform, evidenced by record Q2 results, robust subscription growth, and a significant competitive moat from FDA clearance. Despite near-term competitive discounting and macro caution, raised full-year EBITDA guidance and improved financial flexibility underscore a compelling long-term bullish case as of 2026-08-17, positioning it for durable recurring revenue.
Bull case
Owlet's subscription-first model is gaining significant traction, with Q2 2026 seeing 130,000 paying subscribers, over $1.1 million in MRR, and a 36% penetration rate for Dream Sock users in the U.S. New initiatives like Web Pay and upfront subscription enrollment at the point of purchase are expected to further boost adoption and significantly improve subscription margins by bypassing app store fees.
The company demonstrated exceptional international growth, with Q2 2026 international revenue soaring 214% year-over-year to a record $5.7 million. This expansion, coupled with the goal to win 1 million new customers annually and retain families for at least two years, points towards a recurring base of over 1 million subscribers, leveraging underpenetrated markets in Europe.
Owlet holds a strong competitive advantage as the first and only FDA-cleared baby monitor on the market. Amazon's enforcement of FDA clearance for vital signs monitors, effective August 10, 2026, is expected to provide a significant long-term tailwind by deactivating non-compliant competitors. Additionally, a new $25 million credit facility substantially reduces capital costs.
Bear case
Despite strong Q2 performance, Owlet reaffirmed its full-year 2026 revenue guidance, with Q3 expected to decline sequentially and year-over-year. This reflects aggressive competitive discounting observed prior to Amazon's FDA deadline, which led to an 8% year-over-year drop in Owlet's Prime Day units sold, indicating near-term top-line headwinds.
The raised full-year adjusted EBITDA outlook to $10.75 million-$12.75 million is primarily due to a one-time $3.75 million tariff refund recognized in Q2 2026. Excluding this, underlying expectations are essentially unchanged, suggesting that while operational efficiency is a focus, significant organic improvements in profitability beyond the refund may be slower.
The Owlet OnCall telehealth platform remains in a 'test and learn' phase, with meaningful revenue contribution not expected until next year, delaying immediate financial impact. Furthermore, broader macro signals indicate cautious consumer spending, with the overall baby monitor category on Prime Day being down year-over-year, posing potential market headwinds.
Bull / Bear Case
- Bear Case
- Despite strong Q2 performance, Owlet reaffirmed its full-year 2026 revenue guidance of $118 million to $122 million, with Q3 expected to decline sequentially and year-over-year. This reflects aggressive competitive discounting observed prior to Amazon's FDA deadline, which led to an 8% year-over-year drop in Owlet's Prime Day units sold, indicating near-term top-line headwinds. The raised full-year adjusted EBITDA outlook to $10.75 million-$12.75 million is primarily due to a one-time $3.75 million tariff refund recognized in Q2 2026; excluding this, underlying expectations are essentially unchanged, suggesting slower organic improvements in profitability. The Owlet OnCall telehealth platform remains in a 'test and learn' phase, with meaningful revenue contribution not expected until next year, delaying immediate financial impact. Furthermore, broader macro signals indicate cautious consumer spending, with the overall baby monitor category on Prime Day being down year-over-year, posing potential market headwinds. The company also reports negative profitability metrics such as ROA, ROIC, operating margin, net margin, and free cash flow.
- Bull Case
- Owlet's strategic pivot to a subscription-first, AI-driven pediatric health platform is gaining significant traction, evidenced by 130,000 paying subscribers, over $1.1 million in Monthly Recurring Revenue (MRR), and a 36% penetration rate for Dream Sock users in the U.S.. New initiatives like Web Pay and upfront subscription enrollment are expected to further boost adoption and significantly improve subscription margins by bypassing app store fees. The company demonstrated exceptional international growth, with Q2 2026 international revenue soaring 214% year-over-year to a record $5.7 million. Owlet holds a strong competitive advantage as the first and only FDA-cleared baby monitor on the market, with Amazon's enforcement of FDA clearance for vital signs monitors (effective August 10, 2026) expected to provide a significant long-term tailwind by deactivating non-compliant competitors. Additionally, a new $25 million credit facility substantially reduces capital costs, enhancing financial flexibility.
- More Compelling & Why
- Bull. Given the current Price/Sales (P/S) ratio of approximately 0.93x to 1.7x, which is favorable compared to industry peers (2.3x-2.9x), and the significant post-earnings stock outperformance, the bull case is more compelling. The strongest argument is Owlet's durable competitive moat from being the first and only FDA-cleared baby monitor, which, coupled with Amazon's enforcement, is a structural tailwind expected to drive long-term market share and pricing power. This advantage, alongside robust subscription growth and international expansion, suggests future profitability despite current unprofitability. My view would flip if subscription growth significantly decelerates or if the company fails to demonstrate a clear path to positive underlying operational profitability and free cash flow in the coming quarters, especially if the P/S ratio were to expand without corresponding improvements.
Key Factors
| Key Factor | Why It Matters | What To Watch | What It Signals | Where/How To Track | Free Alt Data | Paid Alt Data |
|---|---|---|---|---|---|---|
| Owlet360 Subscription Growth (Subscribers & MRR) | This is central to Owlet's strategic pivot to a recurring revenue model, extending customer lifetime value and driving long-term profitability. Strong growth validates the platform's value proposition and execution. | Total paying subscribers and Monthly Recurring Revenue (MRR) in Q3 2026 and beyond. Specifically, continued sequential growth beyond Q2's 130,000 subscribers and $1.1 million MRR. Also, the impact of Web Pay and upfront subscription enrollment on these metrics. | Bullish: Sequential growth in subscribers exceeding 130,000 and MRR exceeding $1.1 million in Q3 2026, indicating successful execution of subscription strategy and positive impact from new enrollment methods. Bearish: Stagnation or decline in subscriber count or MRR, suggesting challenges in conversion or retention. | Company's Q3 2026 earnings report and subsequent investor presentations. | Google Trends: 'Owlet 360 subscription' search volume, app store reviews for Owlet app. | Sensor Tower: Owlet app downloads and in-app purchase revenue trends; SimilarWeb: owletcare.com traffic and conversion rates. |
| Owlet360 Subscription Penetration Rate & New Customer Acquisition | Increasing penetration among existing device users and successfully acquiring new customers are vital for expanding the subscription base and achieving the long-term goal of 1 million subscribers. | The reported penetration rate for Dream Sock users in the U.S. for Q3 2026 (compared to Q2's 36%), initial penetration rates for camera users as new features roll out, and progress towards the goal of 1 million new customers annually. Also, the percentage of new users electing the annual plan. | Bullish: Continued increase in Dream Sock user penetration rate (exceeding 36%), strong initial penetration rates for camera users (e.g., >10%), and clear progress or positive commentary on achieving the 1 million new customers per year target. Bearish: Stagnation or decline in penetration rates, or challenges in converting new customers to subscribers. | Company's Q3 2026 earnings report and investor presentations. | Owlet's social media engagement, online parenting forums discussing Owlet 360. | Sensor Tower: Owlet app user engagement metrics; SimilarWeb: owletcare.com new user acquisition trends. |
| Amazon FDA Clearance Enforcement & Competitive Landscape | Amazon's enforcement of FDA clearance creates a significant competitive moat for Owlet, potentially leading to increased market share and reduced competitive pressure from non-cleared products. | Post-August 10, 2026, competitive pricing behavior and product availability on Amazon's platform. Management commentary on the observed impact of enforcement on market share and competitor activity in Q3 and beyond. | Bullish: Amazon's continued strict enforcement leading to a reduction in non-FDA-cleared vital signs monitors, resulting in increased market share for Owlet and/or improved pricing power. Bearish: Weak or inconsistent enforcement by Amazon, or competitors quickly obtaining FDA clearance, negating Owlet's advantage. | Company's Q3 2026 earnings report and management commentary. Independent observation of product listings on Amazon. | Amazon product listings for 'baby vital signs monitor' or 'baby oxygen monitor' (observing product availability and seller information), news articles on FDA enforcement in the baby monitor category. | E-commerce data providers (e.g., Jungle Scout, Helium 10): Amazon sales rank and market share data for baby monitors, particularly for Owlet and its competitors. |
| Core Market Product Sell-Through Growth (U.S. & International) | Sustained sell-through growth in core markets indicates strong demand for Owlet's products and successful market penetration, which is foundational for subscription growth. | Year-over-year growth in U.S. domestic sell-through units for Dream Sock and Duo, and international sell-through growth for Q3 2026. Specifically, whether the underlying growth rates (excluding Prime Day impact) can overcome the competitive discounting and challenging Q3 2025 comparisons. | Bullish: Q3 2026 U.S. sell-through unit growth (adjusted for promotional events) exceeding 20% year-over-year and international sell-through unit growth exceeding 38% year-over-year, indicating resilience against competitive pressures. Bearish: Significant deceleration or decline in sell-through, particularly if it falls below Q2's adjusted growth rates, suggesting competitive discounting had a deeper impact than anticipated. | Company's Q3 2026 earnings report and management commentary on market dynamics. | Industry reports on baby monitor sales, major retailer (Amazon, Target, Walmart) sales rankings for baby monitors. | NielsenIQ: Baby monitor category sales data; Earnest Research: Consumer spending data on Owlet products. |
| Adjusted EBITDA Performance (Excluding One-time Tariff Refunds) | This metric reflects the company's underlying operational efficiency and profitability, crucial for validating its strategic focus on profitable growth. | Q3 2026 Adjusted EBITDA results, specifically the figure *excluding* any one-time tariff refunds, and any further revisions to the full-year 2026 guidance range of $10.75 million to $12.75 million (which already includes the Q2 tariff refund). | Bullish: Q3 Adjusted EBITDA (excluding one-time items) showing continued sequential improvement or exceeding expectations, and/or an upward revision of the full-year guidance *excluding* the tariff refund impact. Bearish: Q3 Adjusted EBITDA (excluding one-time items) missing expectations or a downward revision of the full-year guidance. | Company's Q3 2026 earnings report and financial statements. |
Key Reported Metrics, Reratings Triggers & ResultsInternational markets represent a massive growth opportunity for Owlet, with strong sell-through momentum indicating successful expansion and market penetration
Upcoming print · 2026-11-12
| Key reported metrics | ||
|---|---|---|
| Metric | Last period | Why it matters |
| International Revenue | $5.7 million (214% y/y growth) | International markets represent a massive growth opportunity for Owlet, with strong sell-through momentum indicating successful expansion and market penetration in underpenetrated geographies. Sustained growth signals compounding recurring revenue and long-term value creation. |
| Adjusted EBITDA (excluding one-time tariff refund) | 480% | This metric reflects Owlet's underlying operational efficiency and profitability, separate from one-time benefits. Its growth indicates the success of cost management and the shift to higher-margin revenue streams, which is key for sustainable financial health. |
| Subscription Revenue | $3.2 million (300% y/y growth, 18.5% sequential growth from Q1 2026's $2.7 million), 130,000 paying subscribers, >$1.1 million MRR, 36% Dream Sock user penetration in the U.S. | This metric is crucial as Owlet pivots to a subscription-first model, aiming to extend customer lifetime value and build a recurring revenue base. Continued strong growth validates this strategic shift and its impact on long-term profitability. |
Last reported · 2026-08-11
| Key reported metrics | Rerating thresholds | Earnings results | ||||||
|---|---|---|---|---|---|---|---|---|
| Metric | Last period | Why it matters | What's needed for rerating | Rerating context | Earnings date | Actual reported | Hit target? | Notes |
| International Revenue | 22% | International markets represent a massive growth opportunity for Owlet, with strong sell-through momentum indicating successful expansion and market penetration in underpenetrated geographies. | International Revenue growth of 35% or more year-over-year. | Achieving 35%+ international revenue growth demonstrates successful market penetration in underpenetrated geographies, validating Owlet's strategic focus on core markets and its ability to scale its subscription-first model globally. This signals compounding recurring revenue and long-term value creation, driving a positive rerating. | $5.7 million (214% y/y growth) | Yes | International revenue was a standout in Q2 2026, growing 214% year-over-year, far surpassing the 35% rerating trigger. This marked the highest international revenue quarter in Owlet's history. The company noted significant global momentum, although it also benefited from a favorable year-over-year comparable due to a timing shift in orders in Q2 2025. | |
| Subscription Revenue | 569% | This metric is crucial as Owlet transitions to a subscription-first model, aiming to extend customer lifetime value and build a recurring revenue base. Its strong growth indicates the success of this strategic pivot. | Subscription Revenue needs to hit at least $3.8 million, representing over 40% sequential growth from Q1 2026's $2.7 million. This should be accompanied by a sequential increase of at least 15% in paying subscribers (exceeding 132,250) and Monthly Recurring Revenue (exceeding $1.15 million), and an increase in Dream Sock user penetration in the U.S. above 34%. | Hitting these targets validates Owlet's strategic pivot to a high-margin, recurring revenue model, crucial for long-term profitability and customer lifetime value. Strong subscription growth demonstrates successful execution, enhances competitive position, and signals a clear path to achieving raised adjusted EBITDA guidance, driving a positive rerating. | $3.2 million (300% y/y growth, 18.5% sequential growth from Q1 2026's $2.7 million), 130,000 paying subscribers, >$1.1 million MRR, 36% Dream Sock user penetration in the U.S. | No | While subscription revenue showed strong year-over-year growth, it missed the specific sequential growth target of 40% (achieving 18.5%). The absolute revenue of $3.2 million was below the $3.8 million target. The company also fell short on the subscriber count (130,000 vs. 132,250) and MRR (>$1.1 million vs. >$1.15 million) targets. However, Dream Sock user penetration in the U.S. did exceed the 34% threshold, reaching 36%. | |
| Total Revenue | 6.4% | This is a primary indicator of overall business performance and the impact of strategic decisions, including the intentional exit from lower-margin revenue streams and a more conservative sell-through outlook. | Owlet's Total Revenue for Q2 2026 needs to exceed the analyst consensus estimate of approximately $31.71 million, demonstrating year-over-year growth of over 21.53%. | Exceeding this revenue threshold would validate Owlet's strategic pivot to profitable growth and its subscription-first model. It would signal that the deliberate exit from lower-margin revenue streams is being effectively offset by strong performance in core markets and growing subscription adoption, reinforcing the long-term investment thesis and competitive position. | $33.9 million (29.9% y/y growth) | Yes | Owlet's total revenue for Q2 2026 significantly exceeded the analyst consensus estimate of $31.71 million and demonstrated year-over-year growth well above the 21.53% target. This record-breaking revenue was attributed to broad-based strength, strong international performance, and continued momentum in subscription. | |
Key QuestionsCan Owlet sustain the strong sequential growth in its Owlet360 subscription base, further increase penetration rates, and demonstrate progress in expanding and
Can Owlet sustain the strong sequential growth in its Owlet360 subscription base, further increase penetration rates, and demonstrate progress in expanding and monetizing the Owlet OnCall telehealth platform, particularly with the rollout of Web Pay and upfront subscription enrollment in Q3?
- Question 2
Given the reaffirmed full-year revenue guidance despite Q2 outperformance, and anticipated Q3 sequential and year-over-year decline due to competitive discounting and macro caution, can Owlet successfully navigate these near-term headwinds and will Amazon's enforcement of FDA clearance provide the expected competitive benefit to drive sell-through in core markets over the next quarter?
- Question 3
Can Owlet demonstrate continued improvement in underlying operational efficiency and gross margins (excluding one-time tariff refunds), and will the reduced cost of capital from the new credit facility meaningfully contribute to sustainable adjusted EBITDA growth over the next quarter, despite unchanged underlying expectations?
Earnings Transcript Summary
· 2026Q2 Earnings Call
| 3 Things Management Is Most Focused On | Call Takeaway & Tone | Prior Quarter'S Y/Y Growth By Segment | 3 Things Analysts Most Pressed On (And Mgmt Responses) | Revenue Segments |
|---|---|---|---|---|
| 3 Things Management Is Most Focused On1. Firmly positioning Owlet as a data and services platform through subscription: Management is focused on making subscription the obvious choice for parents, expanding enrollment options beyond in-app sign-up to the point of sale, and testing offers and bundles to drive adoption. They are also adding new features to Owlet 360 to extend lifetime value. 2. Winning roughly 1 million new customers per year: Owlet aims to convert more of the existing demand into new customers by creating offerings that increase overall value, save families money upfront, and grow customer economics over time. 3. Keeping families with Owlet for at least 2 years: The company's goal is to make Owlet more valuable the longer a family uses it, extending engagement beyond the newborn window into years 1 and 2, focusing on sleep, health, and wellness through the Owlet 360 subscription and leveraging its pediatric health data set with AI. | Call Takeaway & ToneThe overall takeaway of the call is that Owlet delivered a record-breaking Q2, driven by strong international growth and continued momentum in its Owlet 360 subscription platform. The company is firmly executing its strategic pivot to a data and services platform, aiming for a durable multi-year subscription relationship with over 1 million subscribers. Despite competitive discounting ahead of the Amazon FDA clearance deadline and broader macro caution, management reaffirmed its full-year revenue outlook while raising its gross margin and adjusted EBITDA guidance, reflecting operational efficiency and a one-time tariff refund. The tone of the call was confident and cautiously optimistic, emphasizing the long-term potential of its category leadership, FDA clearance, and expanding subscription and telehealth offerings. | Prior Quarter'S Y/Y Growth By SegmentIn Q1 2026, total revenue was up 6.4% year-over-year. U.S. domestic sell-through units for Sock and Duo grew 10.5% year-over-year. International revenue grew 22% year-over-year. Specific year-over-year revenue growth for the subscription segment was not explicitly stated for Q1 2026, but it was noted that subscription revenue grew sequentially to a record $2.7 million in Q1. | 3 Things Analysts Most Pressed On (And Mgmt Responses)1. **Subscription attachment rates, retention, and the impact of Web Pay:** Analysts inquired about current subscription attachment rates, retention, and the financial implications of Web Pay. Management responded that around 30% of parents subscribe within the first year, with an average subscriber length of use of about 12 months, and cohorts are just beginning to mature. They noted that nearly 30% of new users in the trial period elect the annual plan, and 36% of the Dream Sock customer base now has a subscription. Regarding Web Pay, management explained that it allows Owlet to bypass the approximately 30% fees paid to app stores for the first 12 months of a subscriber's life, significantly improving subscription margins over time, although the shift in subscriber mix will take time. 2. **Integration and monetization of telehealth (Owlet OnCall) with Owlet 360:** Analysts asked how telehealth would merge into Owlet 360 and drive the subscription model. Management clarified that telehealth is envisioned in tiers, with Owlet 360 already providing health trends and information sharing. A higher tier, Owlet OnCall, will offer access to physicians and is being tested and learned this year to become more accessible and affordable. They anticipate an 'Owlet 360 plus the telehealth offering' model, emphasizing how FDA-cleared data can transform at-home care by enabling doctors to make decisions based on real-time data. 3. **The AI parenting copilot offering, its product roadmap, and monetization:** Analysts questioned the details of the AI parenting copilot. Management explained that Owlet is leveraging its comprehensive and contextualized data set of infant health to build increasingly personalized experiences. They cited the AI morning report, which provides a summary and recommendations based on sleep data, as an example, with 85% daily engagement. This AI functionality is seen as a component of Owlet 360, which may increase in price over time as value grows, with the goal of having all users on Owlet 360 for a sticky, long-term experience. | Revenue SegmentsTotal revenue was $33.9 million, representing a 29.9% increase year-over-year. Subscription revenue grew to $3.2 million, up 300% year-over-year. International revenue grew 214% year-over-year. U.S. total sell-through units, when adjusting for the shift in Prime Day, grew by 12% year-over-year, with Dream Sock increasing 16.5% and Duo increasing 16%. Excluding Prime Day, Q2 total sell-through units grew by 20% year-over-year, with Dream Sock and Duo growth of 21% and 29%, respectively. |
· 2026Q1 Earnings Call
| 3 Things Management Is Most Focused On | Call Takeaway & Tone | Prior Quarter'S Y/Y Growth By Segment | 3 Things Analysts Most Pressed On (And Mgmt Responses) | Revenue Segments |
|---|---|---|---|---|
| 3 Things Management Is Most Focused On1. Prioritizing the Owlet360 subscription and telehealth opportunity: Management is deliberately shifting towards a multi-year subscription model to extend customer lifetime value (LTV) by offering high-value features for up to 4 years, potentially spanning multiple children. This includes launching new features and AI integrations for Dream Sock, new camera subscription features (Dream Sight), and expanding subscription access internationally. The Owlet OnCall telehealth platform has also officially gone live for select participants. 2. Sharpening focus on high-value opportunities within existing core markets: Owlet aims to capitalize on significant growth potential in its current underpenetrated markets, such as the U.S. (11% penetration) and Europe (low single digits). As part of this strategy, the company has deferred planned entries into new geographies like India, Hong Kong, and Singapore, redirecting investments to core markets with higher near-term return potential. 3. Heightened focus on operational efficiency and financial discipline to drive profitable growth: Management is optimizing spending, pausing new global clearances and country launches that incur upfront costs, eliminating previously planned headcount additions by leveraging internal technology and AI, and deferring lower ROI projects outside the core 0-24 month segment. This disciplined approach is intended to improve operating leverage and profitability, even if it results in lower near-term revenue. | Call Takeaway & ToneThe overall takeaway of the call is that Owlet is undergoing a strategic pivot towards profitable growth by prioritizing high-margin subscription services, focusing on core markets, and enhancing operational efficiency. While this involves a revised, more conservative revenue outlook for the near term, it is expected to lead to significantly improved adjusted EBITDA. The tone of the call was cautiously optimistic and confident, with management emphasizing the long-term transformational potential of their subscription and AI-driven pediatric health platform, despite the short-term revenue adjustments. They highlighted strong customer engagement, international growth in existing markets, and the successful initial rollout of new features and services. | Prior Quarter'S Y/Y Growth By SegmentIn Q4 2025, total revenue increased 29.6% year-over-year. International revenue grew 27% year-over-year. For U.S. domestic sell-through, Dream Sock sell-through grew 9% year-over-year, and Dream Duo sell-through increased 53% year-over-year. Specific year-over-year revenue growth for the subscription segment was not explicitly stated, but it was noted as a driver of overall revenue growth and showed sequential growth. Year-over-year growth for BabySat revenue was not explicitly stated for Q4 2025 in the available information. | 3 Things Analysts Most Pressed On (And Mgmt Responses)1. Changes in the latest revenue guidance versus the prior guide: Analysts inquired about the reasons for the updated top-line revenue guidance. Management responded that the revised outlook reflects a sharpened focus on profitable growth, involving the intentional removal of lower-margin, high-burden revenue streams from non-core geographies and new channels. They also incorporated a more conservative view on sell-through for the remainder of the year, emphasizing that this is a purposeful trade-off designed to improve operating leverage and profitability, leading to a raised adjusted EBITDA outlook. 2. Operational expenses (OpEx) increase and opportunities for improved leverage: Analysts questioned the year-over-year increase in OpEx, particularly in G&A, and sought clarification on opportunities for improving operating leverage. Management explained that they had removed significant planned headcount investments, deprioritized entering new geographies (which involve substantial upfront regulatory, quality, engineering, and marketing costs), and are deferring projects outside the core 0-24 month segment. They stated that focusing on higher ROI initiatives allows them to increase investments in those areas while simultaneously decreasing overall OpEx. 3. Subscription growth and retention, and monetization of Owlet OnCall: Analysts pressed on the company's assumptions for subscription growth, annual retention rates, and the monetization strategy for the newly launched Owlet OnCall telehealth platform. Management expressed strong optimism regarding Owlet360, noting that it surpassed internal benchmarks, achieved a nearly 35% penetration rate for Dream Sock users in the U.S., and is expected to continue strong growth. For Owlet OnCall, management clarified that the near-term focus is on testing, learning, and improving the customer experience, with the expectation that it will become a meaningful revenue contributor in future years, similar to the initial approach with the subscription service. They also highlighted meaningful sequential improvements in churn and that the product roadmap, including telehealth and new camera features, is designed to extend LTV to a 4-year family subscription life cycle. | Revenue SegmentsQ1 total revenue was $22.5 million, up 6.4% year-over-year. U.S. domestic sell-through units for Sock and Duo grew 10.5% year-over-year, with Duo increasing 45% and Dream Sock increasing 3%. International revenue grew 22% year-over-year. Subscription revenue grew sequentially to a record $2.7 million in Q1. BabySat revenue grew nearly 100% year-over-year. |
Transcript Tidbits
| About Expanding Eligible Market | About Competition | About The Broader Industry | Where Things Are Headed | Updates On Theme | Broader Themes Emerging | Bullish-Leaning Quotes (Short) | Bearish-Leaning Quotes (Short) |
|---|---|---|---|---|---|---|---|
| About Expanding Eligible MarketOwlet aims to win roughly 1 million new customers per year and keep those families for at least 2 years, pointing towards a recurring base of over 1 million subscribers over time. The company will sell to 600,000 to 700,000 new customers this year alone. International revenue grew 214% year-over-year in Q2 2026, marking the highest international revenue quarter in Owlet history at $5.7 million. Owlet 360 subscription was launched in new non-English-speaking international markets, reaching an additional 5% to 10% of the user base. Europe is a significant growth area, with Germany and France showing strong expansion, and Eastern Europe, particularly the Czech Republic, having high monitoring penetration. The company believes every baby in Europe, similar to the U.S., will eventually have access to health sensing technology. | About CompetitionOwlet holds a dominant position as the first and only FDA-cleared baby monitor on the market and is consistently the market leader in dollars spent in the category. Amazon notified sellers that baby monitoring products measuring vital signs without FDA clearance would be deactivated by August 10, 2026, a requirement Owlet's Dream Sock already meets. This enforcement is expected to provide a longer-term competitive benefit for Owlet, as competitors would need to undergo the same rigorous FDA clearance process. Following Amazon's letter, competitors engaged in aggressive discounting, leading to Owlet's Prime Day units sold being down 8% year-over-year, though Owlet remained #1 in baby monitoring and safety. | About The Broader IndustryThe pediatric health and wellness market is still early, presenting a significant opportunity for Owlet. The FDA issued a safety communication warning against over-the-counter infant monitors making unsubstantiated claims without review for safety and effectiveness. The baby monitor category on Prime Day was down year-over-year, with consumers appearing to spend more cautiously and prioritizing everyday essentials, a trend observed across several large Amazon promotional events. There is a significant communication gap in newborn care, where pediatricians often recommend ER visits for concerns without data, a paradigm Owlet aims to change with FDA-cleared at-home data. | Where Things Are HeadedOwlet is evolving into a data and services platform for the earliest years of a child's life, aiming to integrate sleep, health monitoring, camera, and telehealth into a single Owlet experience. The company's objectives are to firmly position Owlet as a data and services platform through subscription, win roughly 1 million new customers annually, and retain families for at least 2 years, building towards a recurring base of over 1 million subscribers. Owlet 360 subscription is the vehicle to extend lifetime value by delivering the best of Owlet beyond the newborn window into years 1 and 2. The company is leveraging its pediatric health data set and AI to build increasingly personalized experiences across sleep, health, and wellness. Owlet OnCall is being developed into a more seamless and proactive experience to connect parents with clinical resources, with learnings this year expected to set up a meaningful new revenue stream next year. The company is reaffirming its full-year 2026 revenue outlook of $118 million to $122 million and raising its adjusted EBITDA outlook to $10.75 million to $12.75 million, reflecting the onetime tariff refund. | Updates On ThemeChild | Broader Themes EmergingThe industry is seeing a significant shift from one-time hardware sales to durable multiyear subscription relationships, emphasizing data and services platforms. There's an increasing integration of AI to provide personalized experiences, insights, and guidance in pediatric health and wellness. The expansion of telehealth services is a notable trend, aiming to connect parents with clinical resources more seamlessly and proactively. Companies are optimizing payment processing by moving to web-based checkouts to improve subscription margins by reducing third-party fees. Broader macroeconomic signals indicate consumers are spending more cautiously and prioritizing everyday essentials. | Bullish-Leaning Quotes (Short)Owlet is evolving more and more into a data and services platform for the earliest years of a child's life. We're the first and only FDA-cleared baby monitor on the market. If Amazon continues to enforce this requirement, we believe it could provide a longer-term competitive benefit for Owlet. International was a standout in the quarter with revenue growing 214% year-over-year. We ended Q2 with 130,000 paying subscribers, generating $3.2 million in revenue, up $2.4 million year-over-year. We are raising our full year adjusted EBITDA outlook to a range of $10.75 million to $12.75 million. | Bearish-Leaning Quotes (Short)Owlet's units sold during Prime Day were down 8% versus last year's event, underperforming our expectations. Prime Day's baby monitor category was down versus last year with consumers appearing to spend more cautiously and prioritizing everyday essentials. For Q3, we expect to decline both sequentially and versus Q3 2025, reflecting that deep competitor discounting discussed. We are observing some broader macro signals we want to be cautious about. |
| About Expanding Eligible Market | About Competition | About The Broader Industry | Where Things Are Headed | Updates On Theme | Broader Themes Emerging | Bullish-Leaning Quotes (Short) | Bearish-Leaning Quotes (Short) | Hiring |
|---|---|---|---|---|---|---|---|---|
| About Expanding Eligible MarketOwlet aims to evolve its customer relationship from a one-time user to a 4-year subscriber by extending high-value subscription features across a child's first two years, with the potential to extend across multiple children, compounding its recurring subscriber base into the millions. The company sees substantial room for expansion within its existing footprint, with underpenetrated markets of just under 20 million children under 24 months of age in current geographies, and market penetration at just over 11% in the U.S. and low single digits in Europe. Owlet believes the business can scale to over 1 million new customers annually over time. International revenue grew 22% year-over-year in Q1, with sell-through up 37% year-over-year. The Czech Republic already has nearly 9% of all babies born using an Owlet, and markets like the U.K., Germany, France, and Australia are on a similar trajectory for market penetration as the U.S. Given that more babies are born in Europe than the U.S., the growth opportunity in Europe is considered massive. Subscription achieved a 34% penetration rate for Dream Sock users in the U.S. in the first quarter. | About CompetitionOwlet was the only brand in the baby monitoring category to grow in Q1 2026, with its dollars growing 11% while the overall category, excluding Owlet, was down 19% in dollars versus prior year Q1. The company is optimizing marketing and retail placements in Q2 to accelerate momentum and take share from competitors. | About The Broader IndustryThe baby monitoring category, excluding Owlet, experienced a general decline, being down 19% in dollars versus prior year Q1. Q1 is seasonally the lowest revenue quarter due to a lack of promotions, and customers are believed to be delaying purchases in anticipation of key promotional events like Mother's Day and Pride Day. The highest rate of healthcare utilization occurs in the first years of life. | Where Things Are HeadedOwlet is sharpening its focus on execution and concentrating resources on its highest value opportunities, prioritizing the Owlet360 subscription and telehealth. The company is transitioning from a hardware-centric sales model to a multi-year subscription model, aiming to compound its recurring subscriber base into the millions. Owlet is building a generational opportunity on AI, leveraging its pediatric health data set, FDA-cleared hardware, and trusted parent relationships to deliver personalized, proactive infant care and establish itself as a defining pediatric health platform in the AI era. The company is consolidating focus and resources on high-value opportunities within existing core markets and deferring planned entries into India, Hong Kong, and Singapore. A heightened focus on operational efficiency and financial discipline is intended to drive profitable growth, including pausing new global clearances and delaying country launches that carry upfront costs, and deferring lower ROI projects outside the core 0 to 24-month segment. Owlet adjusted its full-year 2026 revenue guidance to $118 million to $122 million (12% to 15% year-over-year growth) from the previous $126 million to $130 million, reflecting the decision to exit lower-margin revenue streams and a more conservative sell-through outlook. Concurrently, full-year 2026 adjusted EBITDA guidance was raised to $7 million to $9 million (250% to 350% growth) from $3 million to $5 million, prioritizing operating leverage and profitability. The Owlet OnCall telehealth service is officially going live in the app for select participants, with plans to scale access and learn from the initiative, expecting it to be a meaningful revenue contributor in future years. | Updates On ThemeOwlet | Broader Themes EmergingAI-driven efficiencies are being leveraged to eliminate planned headcount additions and achieve more with fewer resources. The company is shifting towards a subscription-first approach across its business, indicating a broader trend towards recurring revenue models. The launch of Owlet OnCall telehealth highlights the integration of digital health platforms and professional medical consultation to simplify access to care and potentially reduce healthcare costs. | Bullish-Leaning Quotes (Short)This evolution from a hardware-centric sales to a multiyear subscription model fundamentally shifts our growth trajectory, compounding our recurring subscriber base into the millions. Owlet is building a generational opportunity on AI, anchored by what we believe is the most scaled pediatric health data set in the world. We believe the business has the potential to scale toward over 1 million new customers annually over time. Owlet was the only brand in the category to grow during a period of general decline. Brand health remains exceptional, evidenced by a Dream Sock NPS of 77 and a blended product NPS of 71. We're excited to report that this week, Owlet OnCall telehealth is officially going live in our app for select participants. I've just never been more confident in Owlet's path. | Bearish-Leaning Quotes (Short)For the full year, we are adjusting our revenue guidance to a range of $118 million to $122 million, representing 12% to 15% year-over-year growth compared to our previous guidance of $126 million to $130 million. This revised range accounts for our deliberate decision to exit lower-margin, high-burden revenue streams in noncore geographies and new channels. Additionally, this outlook incorporates a more conservative view on sell-through for the remainder of the year. While this disciplined approach may result in lower near-term revenue, it is a purposeful trade-off designed to improve operating leverage and profitability. Excluding Owlet, the baby monitoring category was down 19% in dollars versus prior year Q1. Q1 operating loss was $5.5 million compared to $2.7 million in the same period last year. Adjusted EBITDA was down versus prior year, primarily a result of tariff cost impacts. | HiringOwlet has eliminated previously planned headcount additions by leveraging internal technology and AI-driven efficiencies to grow efficiently with fewer resource constraints. Personnel expenses increased due to the full-period impact of headcount additions made throughout 2025 and strategic new hires in the current quarter. Stock-based compensation also increased due to expanded headcount and the timing of long-term incentive plan grants. The company determined it would not be adding as many headcount as initially planned, believing it can achieve more with less, and these planned additions have been removed from the plan. |
| About Expanding Eligible Market | About Competition | About The Broader Industry | Where Things Are Headed | Updates On Theme | Broader Themes Emerging | Bullish-Leaning Quotes (Short) | Bearish-Leaning Quotes (Short) | Hiring |
|---|---|---|---|---|---|---|---|---|
| About Expanding Eligible MarketOwlet aims to evolve its customer relationship from a one-time user to a 4-year subscriber by extending high-value subscription features across a child's first two years, with the potential to extend across multiple children, compounding its recurring subscriber base into the millions. The company sees substantial room for expansion within its existing footprint, with underpenetrated markets of just under 20 million children under 24 months of age in current geographies, and market penetration at just over 11% in the U.S. and low single digits in Europe. Owlet believes the business can scale to over 1 million new customers annually over time. International revenue grew 22% year-over-year in Q1, with sell-through up 37% year-over-year. The Czech Republic already has nearly 9% of all babies born using an Owlet, and markets like the U.K., Germany, France, and Australia are on a similar trajectory for market penetration as the U.S. on a year-by-year basis. Given that more babies are born in Europe than the U.S., the growth opportunity in Europe is considered massive. Subscription achieved a 34% penetration rate for Dream Sock users in the U.S. in the first quarter. | About CompetitionOwlet was the only brand in the baby monitoring category to grow in Q1 2026, with its dollars growing 11% while the overall category, excluding Owlet, was down 19% in dollars versus prior year Q1. The company is optimizing marketing and retail placements in Q2 to accelerate momentum and take share from competitors. | About The Broader IndustryThe baby monitoring category, excluding Owlet, experienced a general decline, being down 19% in dollars versus prior year Q1. Q1 is seasonally the lowest revenue quarter due to a lack of promotions, and customers are believed to be delaying purchases in anticipation of key promotional events like Mother's Day and Pride Day. The highest rate of healthcare utilization occurs in the first years of life. | Where Things Are HeadedOwlet is sharpening its focus on execution and concentrating resources on its highest value opportunities, prioritizing the Owlet360 subscription and telehealth. The company is transitioning from a hardware-centric sales model to a multi-year subscription model, aiming to compound its recurring subscriber base into the millions. Owlet is building a generational opportunity on AI, leveraging its pediatric health data set, FDA-cleared hardware, and trusted parent relationships to deliver personalized, proactive infant care and establish itself as a defining pediatric health platform in the AI era. The company is consolidating focus and resources on high-value opportunities within existing core markets and deferring planned entries into India, Hong Kong, and Singapore. A heightened focus on operational efficiency and financial discipline is intended to drive profitable growth, including pausing new global clearances and delaying country launches that carry upfront costs, and deferring lower ROI projects outside the core 0 to 24-month segment. Owlet adjusted its full-year 2026 revenue guidance to $118 million to $122 million (12% to 15% year-over-year growth) from the previous $126 million to $130 million, reflecting the decision to exit lower-margin revenue streams and a more conservative sell-through outlook. Concurrently, full-year 2026 adjusted EBITDA guidance was raised to $7 million to $9 million (250% to 350% growth) from $3 million to $5 million, prioritizing operating leverage and profitability. The Owlet OnCall telehealth service is officially going live in the app for select participants, with plans to scale access and learn from the initiative, expecting it to be a meaningful revenue contributor in future years. | Updates On ThemeOwlet | Broader Themes EmergingAI-driven efficiencies are being leveraged to eliminate planned headcount additions and achieve more with fewer resources. The company is shifting towards a subscription-first approach across its business, indicating a broader trend towards recurring revenue models. The launch of Owlet OnCall telehealth highlights the integration of digital health platforms and professional medical consultation to simplify access to care and potentially reduce healthcare costs. | Bullish-Leaning Quotes (Short)This evolution from a hardware-centric sales to a multiyear subscription model fundamentally shifts our growth trajectory, compounding our recurring subscriber base into the millions. Owlet is building a generational opportunity on AI, anchored by what we believe is the most scaled pediatric health data set in the world. We believe the business has the potential to scale toward over 1 million new customers annually over time. Owlet was the only brand in the category to grow during a period of general decline. Brand health remains exceptional, evidenced by a Dream Sock NPS of 77. Owlet OnCall telehealth is officially going live in our app for select participants. I've just never been more confident in Owlet's path. | Bearish-Leaning Quotes (Short)For the full year, we are adjusting our revenue guidance to a range of $118 million to $122 million, representing 12% to 15% year-over-year growth compared to our previous guidance of $126 million to $130 million. This revised range accounts for our deliberate decision to exit lower-margin, high-burden revenue streams in noncore geographies and new channels. Additionally, this outlook incorporates a more conservative view on sell-through for the remainder of the year. While this disciplined approach may result in lower near-term revenue, it is a purposeful trade-off designed to improve operating leverage and profitability. Excluding Owlet, the baby monitoring category was down 19% in dollars versus prior year Q1. Q1 operating loss was $5.5 million compared to $2.7 million in the same period last year. Adjusted EBITDA was down versus prior year, primarily a result of tariff cost impacts. | HiringOwlet has eliminated previously planned headcount additions by leveraging internal technology and AI-driven efficiencies, aiming to grow efficiently with fewer resource constraints. The rise in personnel expenses in Q1 reflects the full period impact of headcount additions made throughout 2025, supplemented by strategic new hires in the current quarter. Stock-based compensation also increased due to expanded headcount and the timing of long-term incentive plan grants. The company determined it would not be adding as many headcount as initially planned, believing it can achieve more with less through AI and other transformations. |
Upcoming Events
| Catalyst ID | Estimated Timing | Estimated Date Start | Estimated Date End | Catalyst | Why It Matters | Ticker Or Theme Specific | Transcript Date | Source Type |
|---|---|---|---|---|---|---|---|---|
| OWLT_5f3a08fa | If Amazon continues to enforce this requirement (post August 10, 2026) | 2026-08-11 | 2026-11-11 | Continued enforcement by Amazon of its policy to deactivate baby monitoring products that measure vital signs and lack FDA clearance. | This provides a significant competitive advantage for Owlet's FDA-cleared Dream Sock, potentially leading to increased market share and sales as non-compliant competitors are removed from the platform. | Ticker | 2026-08-11 | earnings_transcript |
| OWLT_e3f1bb41 | rolling Web Pay out in Q3 | 2026-07-01 | 2026-09-30 | Full rollout of Web Pay, moving Owlet 360 subscription enrollment and billing onto Owlet's own web-based checkout. | This is expected to improve subscription margins by reducing third-party payment fees and provide greater flexibility for enrolling subscribers at the point of purchase, potentially boosting adoption and profitability. | Ticker | 2026-08-11 | earnings_transcript |
| OWLT_1da64ccc | this year | 2026-07-02 | 2026-12-31 | Owlet plans to launch new features and AI integrations for Dream Sock to enhance its subscription value proposition and support continued increases in its attach rate. | Successful launches of these features could increase the Dream Sock subscription attach rate, extend customer lifetime value, and drive recurring revenue growth, positively impacting financial results and investor sentiment. | Ticker | 2026-05-07 | earnings_transcript |
| OWLT_7d0b4a75 | this year | 2026-07-02 | 2026-12-31 | Owlet plans to expand Owlet360 subscription access to its large and growing customer base outside of the U.S. | This international expansion could significantly increase the recurring subscriber base and overall subscription revenue by tapping into new markets, contributing to top-line growth and valuation. | Ticker | 2026-05-07 | earnings_transcript |
| OWLT_9ebeaf0f | this year | 2026-07-02 | 2026-12-31 | Owlet is launching compelling new camera subscription features, such as built-in white noise, to deliver value to nightly active cam users and extend the Owlet360 subscription. | These new camera features aim to increase engagement and retention for camera users, potentially extending customer lifetime value and supporting long-term Owlet360 subscription growth and recurring revenue. | Ticker | 2026-05-07 | earnings_transcript |
| OWLT_5267a9df | over the coming weeks and months to test and learn | 2026-07-02 | 2027-12-31 | Owlet is scaling access to its Owlet OnCall telehealth service, enabling parents to communicate directly with pediatricians within the app. | This initiative is expected to provide deeper value to parents, extend customer relationships, and is anticipated to fuel a significant new revenue stream for the business in future years, impacting long-term growth and valuation. | Ticker | 2026-05-07 | earnings_transcript |